Alpha Cognition Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Grapevine, TX
ACOG chart
What traders are saying about $ACOG
Latest postsAlpha Cognition Inc. news
- Alpha Cognition appoints Caren Deardorf to its board of directors
StreetInsider ·
- Alpha Cognition Appoints Former Biogen Executive Caren Deardorf to Board of Directors
citybiz ·
- Alpha Cognition appoints Caren Deardorf to board of directors
Investing.com ·
- Alpha Cognition Strengthens Its Board of Directors with Appointment of Caren Deardorf
Yahoo Finance ·
- Foghorn Therapeutics Inc. (FHTX) Q3 Earnings and Revenues Beat Estimates
Yahoo Finance ·
- Alpha Cognition Inc. Common Stock (ACOG) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Alpha Cognition to Participate in Upcoming Investor Events
Yahoo Finance ·
- Halozyme Therapeutics (HALO) Tops Q3 Earnings and Revenue Estimates
Yahoo Finance ·
- Urogen Pharma (URGN) Reports Q3 Loss, Beats Revenue Estimates
Yahoo Finance ·
- Alpha Cognition to Report Third Quarter 2026 Financial Results and Provide Business Update
Yahoo Finance ·
- Alpha Teknova (TKNO) Stock Jumps 5.1%: Will It Continue to Soar?
Yahoo Finance ·
- Alpha Cognition Announces Publication of U.S. Patent Application Relating to Proprietary Manufacturing Process for ZUNVEYL®
Yahoo Finance ·
Alpha Cognition Inc. key financials
| USD | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | $10.2M | – | – |
| Net income | -$20.7M | -$14.8M | -$13.8M |
| Diluted EPS | $-1.18 | $-2.04 | $-3.84 |
| Total assets (year end) | $79.7M | $50.7M | $2.5M |
| Cash and equivalents (year end) | $66.0M | $48.5M | $1.4M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
- 10-QQUARTERLY REPORT
- 8-KCURRENT REPORT
- 10-QQUARTERLY REPORT
- 8-K/AFORM 8-K/A
- DEF 14ADEFINITIVE PROXY STATEMENT
- 8-KFORM 8-K
- 8-KCURRENT REPORT
- 10-KANNUAL REPORT
- 8-KCURRENT REPORT
- 8-KCURRENT REPORT
- 8-KCURRENT REPORT
- 8-KFORM 8-K
About Alpha Cognition Inc.
- Ticker
- ACOG (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Grapevine, TX
- Incorporated in
- British Columbia, Canada
- Fiscal year end
- December 31
- SEC CIK
- 1655923
- Former names
- Neurodyn Cognition Inc.
Frequently asked questions
What exchange is Alpha Cognition Inc. listed on?
Alpha Cognition Inc. trades on the Nasdaq under the ticker symbol ACOG.
What industry is Alpha Cognition Inc. in?
Alpha Cognition Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Alpha Cognition Inc. headquartered?
Alpha Cognition Inc.'s business address on file with the SEC is in Grapevine, TX.
When does Alpha Cognition Inc.'s fiscal year end?
Alpha Cognition Inc.'s fiscal year ends on December 31.
How much revenue did Alpha Cognition Inc. report?
Alpha Cognition Inc. reported $10.2M in revenue for calendar year 2025, according to its SEC filings.